VEGF has been shown to suppress the activation of tumor-associated endothelial cells and downregulate endothelial cell-selective adhesion molecule (ESAM), a key mediator of leukocyte adhesion and transendothelial migration. The gene discussed is VEGFA; the disease is neoplasm.